Viewing Study NCT01180816

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2026-03-06 @ 7:41 PM
Study NCT ID: NCT01180816
Status: COMPLETED
Last Update Posted: 2021-03-04
First Post: 2010-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
Sponsor: Northwell Health
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma Multiforme View
None Anaplastic Astrocytoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GBM View
None AA View
None AO View
None Brain View
None Tumors View
None Malignant View
None Glioblastoma View
None Multiforme View
None Anaplastic View
None Astrocytoma View